Paddock Labs Attorney Fee Bid Nixed

Law360, New York (December 20, 2007, 12:00 AM EST) -- After having delayed a ruling on defendant Paddock Laboratories Inc.'s motion for attorneys' fees and costs while Schwartz Pharma AG appealed an October 2006 decision to grant summary judgment to Paddock in a patent suit over the hypertension drug Univasc, the district court has denied Paddock's bid for fees, and advised both sides to move on.

U.S. District Judge Ann D. Montgomery signed off on a ruling on Dec. 18, holding that Paddock had not demonstrated that the case was exceptional, and going on to say...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.